(Q47887267)

English

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

author name string

Jonas Hugosson

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

Gunnar Aus

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

Pär Lodding

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

Carl-Gustav Pihl

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

100

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

1397-1405

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

Impact of screening on incidence and mortality of prostate cancer in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

21 January 2018

Breast screening, prognostic factors and survival – results from the Swedish two county study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

21 January 2018

What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

21 January 2018

Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of screening on prostate cancer rates and trends

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of trends in prostate-cancer mortality in England and Wales and the USA.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic Methods in the Detection of Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Interval cancers in the Dutch breast cancer screening programme.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20126

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20126

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/15042673

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47887267&oldid=2174819520"